Representations show that manufacturers like Tata-owned Tinplate Company of India (TCIL), O P Jindal group’s JSW Vallabh Tinplate Pvt (VTPL) and Parikh Group of Companies’s GPT Steel Industries (GPT) together have a capacity of 660,000 tonnes.
The departments are expected to work out other viable options of resolving this issue as well and come back with a proposal “at the earliest”, a senior government official said on condition of anonymity.
In India’s diverse pharma industry, it’s not about how big the firm is, but how popular they can make their brands. This has allowed lesser-known drug makers to build brands that are to be reckoned with
Over the last two years, US put pressure on India by increasing tariffs on products like steel and aluminium,as well as removing the country from its Generalized System of Preferences, which allowed Indian businesses certain trade benefits.
A proposal to allow patients to seek compensation for faulty medical devices, a scrutinised industry following government and media investigations into the adverse impacts of certain hip implants by J&J, is also yet to fructify.
The Central Drugs Standard Control Organisation (CDSCO) alert on Saturday comes over a week after the US Food and Drug Administration (US FDA) flagged five such models of Medtronic’s pacemakers and cardiac resynchronisation therapy pacemakers (CRT-P) for issues related to their batteries.
According to a notification issued on Thursday by the CDSCO, the practice of changing the key therapeutic ingredients in a drug formulation without changing the brand name “is not only misleading but may also result in undesirable pharmacological effects as the consumer would take the formulation assuming that it has the earlier composition.”
J&J, earlier this month, announced that it would be providing 10,000 courses of bedaquiline, used to treat multi drug-resistant TB, “free of charge” to India through USAID in addition to the 10,000 courses it had committed before.